Assessing the risk of concurrent mycoplasma pneumoniae pneumonia in children with tracheobronchial tuberculosis: retrospective study

被引:0
|
作者
Liu, Lin [1 ]
Jiang, Jie [1 ]
Wu, Lei [1 ]
Zeng, De miao [2 ]
Yan, Can [1 ]
Liang, Linlong [1 ]
Shi, Jiayun [1 ]
Xie, Qifang [1 ]
机构
[1] Univ South China, Affiliated Changsha Cent Hosp, Hengyang Med Sch, Dept Pediat, Changsha, Hunan, Peoples R China
[2] Kunming Med Univ, Southern Cent Hosp Yunnan Prov, Peoples Hosp Honghe State 1, Dept Joint Surg,HeHonghe Affiliated Hosp, Changsha, Hunan, Peoples R China
来源
PEERJ | 2024年 / 12卷
关键词
Machine learning; Extreme gradient boosting; Child; Tuberculosis; Tracheobronchial; Pneumonia; Mycoplasma;
D O I
10.7717/peerj.17164
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Objective: This study aimed to create a predictive model based on machine learning to identify the risk for tracheobronchial tuberculosis (TBTB) occurring alongside Mycoplasma pneumoniae pneumonia in pediatric patients. Methods: Clinical data from 212 pediatric patients were examined in this retrospective analysis. This cohort included 42 individuals diagnosed with TBTB and Mycoplasma pneumoniae pneumonia (combined group) and 170 patients diagnosed with lobar pneumonia alone (pneumonia group). Three predictive models, namely XGBoost, decision tree, and logistic regression, were constructed, and their performances were assessed using the receiver's operating characteristic (ROC) curve, precision-recall curve (PR), and decision curve analysis (DCA). The dataset was divided into a 7:3 ratio to test the first and second groups, utilizing them to validate the XGBoost model and to construct the nomogram model. Results: The XGBoost highlighted eight significant signatures, while the decision tree and logistic regression models identified six and five signatures, respectively. The ROC analysis revealed an area under the curve (AUC) of 0.996 for XGBoost, significantly outperforming the other models (p < 0.05). Similarly, the PR curve demonstrated the superior predictive capability of XGBoost. DCA further confirmed that XGBoost offered the highest AIC (43.226), the highest average net benefit (0.764), and the best model fit. Validation efforts confirmed the robustness of the findings, with the validation groups 1 and 2 showing ROC and PR curves with AUC of 0.997, indicating a high net benefit. The nomogram model was shown to possess significant clinical value. Conclusion: Compared to machine learning approaches, the XGBoost model demonstrated superior predictive efficacy in identifying pediatric patients at risk of concurrent TBTB and Mycoplasma pneumoniae pneumonia. The model's identification of critical signatures provides valuable insights into the pathogenesis of these conditions.
引用
收藏
页数:17
相关论文
共 50 条
  • [21] A comparative study of general and severe mycoplasma pneumoniae pneumonia in children
    Yang, Shuo
    Lu, Sukun
    Guo, Yinghui
    Luan, Wenjun
    Liu, Jianhua
    Wang, Le
    BMC INFECTIOUS DISEASES, 2024, 24 (01)
  • [22] Study on childlike nursing in the treatment of children with mycoplasma pneumoniae pneumonia
    Zhou, Ru
    INTERNATIONAL JOURNAL OF MENTAL HEALTH NURSING, 2024, 33 : 47 - 48
  • [23] Azithromycin, erythromycin and doxycycline in the treatment of Mycoplasma pneumoniae pneumonia: A retrospective study
    Kuzman, I
    Schonwald, S
    Culig, J
    Oreskovic, K
    10TH MEDITERRANEAN CONGRESS OF CHEMOTHERAPY, 1996, : 211 - 214
  • [24] Mycoplasma pneumoniae pneumonia in children: Clinical characteristics and risk factors of refractory pneumonia by age
    Kim, Hyung Young
    Park, Hee Ju
    ALLERGY ASTHMA & RESPIRATORY DISEASE, 2018, 6 (06): : 295 - 302
  • [25] Clinical Characteristics and Risk Factors of Mycoplasma pneumoniae Pneumonia with Atelectasis in Children
    Jung, S. S.
    Kim, Y. A.
    Lee, M. R.
    PEDIATRIC PULMONOLOGY, 2022, 57 : S99 - S99
  • [26] Effect of Early Oral Administration of Doxycycline on Macrolide Resistance in Children with Mycoplasma Pneumoniae Pneumonia: A Retrospective Study
    Cai, Bingbing
    Yang, Lei
    Li, Xin
    Zhang, Xin
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2024, 85 (12)
  • [27] Clinical characteristics and predictive indictors of macrolide-unresponsive Mycoplasma pneumoniae pneumonia in children: a retrospective study
    Li, Yun
    Liu, Yunwei
    Chen, Xinying
    Xiao, Xiaolan
    Chen, Yiting
    Wang, Lianyu
    Jiang, Wenwen
    Yang, Jinghua
    FRONTIERS IN PEDIATRICS, 2024, 12
  • [28] Clinical Characteristics of Macrolide-Refractory Mycoplasma pneumoniae Pneumonia in Korean Children: A Multicenter Retrospective Study
    Choi, Yun Jung
    Chung, Eun Hee
    Lee, Eun
    Kim, Chul-Hong
    Lee, Yong Ju
    Kim, Hyo-Bin
    Kim, Bong-Seong
    Kim, Hyung Young
    Cho, Yoojung
    Seo, Ju-Hee
    Sol, In Suk
    Sung, Myongsoon
    Song, Dae Jin
    Ahn, Young Min
    Oh, Hea Lin
    Yu, Jinho
    Jung, Sungsu
    Lee, Kyung Suk
    Lee, Ju Suk
    Jang, Gwang Cheon
    Jang, Yoon-Young
    Chung, Hai Lee
    Choi, Sung-Min
    Han, Man Yong
    Shim, Jung Yeon
    Kim, Jin Tack
    Kim, Chang-Keun
    Yang, Hyeon-Jong
    Suh, Dong In
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (02)
  • [29] Thromboembolic complications of Mycoplasma pneumoniae pneumonia in children
    Chen, Lanqin
    Yin, Ju
    Liu, Xiuyun
    Liu, Jun
    Xu, Baoping
    Shen, Kunling
    CLINICAL RESPIRATORY JOURNAL, 2023, 17 (03): : 187 - 196
  • [30] Cytokine Responses in the Children with Mycoplasma pneumoniae Pneumonia
    Chung, H.
    Lee, H.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2010, 125 (02) : AB151 - AB151